AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer medicines.
www.bloomberg.com
#AstraZeneca #Profit #Revenue #Lifted #Cancer #Drugs
AstraZeneca Profit, Revenue Lifted by Cancer Drugs
